Peptide Atlas / research workspace

Evidence relationships.

Trace what was compared, studied together or simply shares a target. Each connection has its own source and limits; gaps remain unknown.

8 canonical compoundsChecked 5 October 2026Clinical review pending

General context, not a pair finding: unapproved products may have uncertain identity, sterility or manufacturing. TGA advisory · Clinical review pending.

Comparison canvas / 2 of 4

Selected compounds

Research example, not a recommendation.

Semaglutide

Cagrilintide

Empty position 3

Empty position 4

Drag a result here or use Add; pairwise records do not evaluate the whole set.

Pairwise evidence does not establish set-level safety or benefit.

Add or search compounds

Evidence map / 1 unique pairs · 1 relation records

Connections & gaps

M ··· shared mechanismH ━ human study (design in label)C ━ ━ comparison! ··· U.S. label: not recommendedI ━ · identity? ··· no relation record

Select a lettered relation anchor to inspect sources and limits. Dotted “?” means no curated relation record. All pairs and coadministration gaps appear below.

Semaglutide · Cagrilintide

Pair coverage · 1 of 1 pairs accounted for

Semaglutide + Cagrilintide

Human coadministration record: randomized trial

1 separate relation: Studied together · REDEFINE 1

Shared target ≠ synergy. Direct comparison ≠ coadministration. Unknown ≠ safe or harmful. Pairwise evidence cannot evaluate a 3–4-item set.

Curated relationship snapshot checked 5 October 2026 · clinical review pending · source checking is not clinical validation. Original catalogue: 118 sources, kept separate from 8 relationship records using 5 additional relationship sources. No personal data, AI search, scoring or clinical advice. Browse all 32 catalogue entries